Targeting DNA repair with combination veliparib (ABT-888) and temozolomide in patients with metastatic castration-resistant prostate cancer.
Investigational new drugs.
Times cited: 16
Phase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research.
Times cited: 191